Archives

Agentis Longevity and Ultrahuman Forge Landmark Partnership to Redefine the Standard of Personalized Affordable Healthcare

B Partnership Brings World-Class Biosensor Data and the Longevity Quotient Together to Deliver an Unmatched Patient Experience at a Price Everyone Can Access NASHVILLE, Tenn.,… Login to continue reading Login…

Read MoreAgentis Longevity and Ultrahuman Forge Landmark Partnership to Redefine the Standard of Personalized Affordable Healthcare

Gan & Lee Pharmaceuticals’ Once-Weekly Basal Insulin GZR4 Injection Meets Primary Endpoints in Two Pivotal Phase 3 Clinical Trials: SUPER-1 and SUPER-2

B BEIJING and BRIDGEWATER, N.J., March 31, 2026 /PRNewswire/ — Gan & Lee Pharmaceuticals (SSE: 603087) today announced that two pivotal phase 3 clinical trials, SUPER-1 and… Login to continue reading Login…

Read MoreGan & Lee Pharmaceuticals’ Once-Weekly Basal Insulin GZR4 Injection Meets Primary Endpoints in Two Pivotal Phase 3 Clinical Trials: SUPER-1 and SUPER-2